A human cytochrome P-450 (P450) 1B1 cDNA was expressed in Saccharomyces cerevisiae and the microsomes containing P450 1B1 were used to examine the selectivity of this enzyme in the activation of a variety of environmental carcinogens and mutagens in Salmonella typhimurium TA1535/pSK1002 or NM2009 tester strains, using the SOS response as an end point of DNA damage. We also determined and compared these activities of P450 1B1 with those catalyzed by recombinant human P450s 1A1 and 1A2, which were purified from membranes of Escherichia coli. The carcinogenic chemicals tested included 27 polycyclic aromatic hydrocarbons and their dihydrodiol derivatives, 17 heterocyclic and aryl amines and aminoazo dyes, three mycotoxins, two nitroaromatic hydrocarbons, N-nitrosodimethylamine, vinyl carbamate, and acrylonitrile. Among the three P450 enzymes examined here, P450 lB1 was found to have the highest catalytic activities for the activation of 11,12-dihydroxy-11,12-dihydrodibenzo[a,l]pyrene, 1,2-dihydroxy-1,2-dihydro-5-methylchrysene, (+)-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, 11,12-dihydroxy-11,12-dihydrobenzo[g]chrysene, 3,4-dihydroxy-3,4-dihydrobenzo[c]phenanthrene, 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole, 2-aminoanthracene, 3-methoxy-4-aminoazobenzene, and 2-nitropyrene. P450 1B1 also catalyzed the activation of 2-amino-3,5-dimethylimidazo[4,5-f]quinoline, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline, 2-amino-3-methylimidazo[4,5-f]quinoline, 2-aminofluorene, 6-aminochrysene and its 1,2-dihydrodiol, (-)-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, 1,2-dihydroxy-1,2-dihydrochrysene, 1,2-dihydroxy-1,2-dihydro-5,6-dimethylchrysene, 2,3-dihydroxy-2,3-dihydrofluoranthene, 3,4-dihydroxy-3,4-dihydro-7,12-dimethylbenz[a]anthracene, and 6-nitrochrysene to appreciable extents. However, P450 1B1 did not produce genotoxic products from benzo[a]pyrene, trans- 3,4-dihydroxy-3,4-dihydrobenzo[a]anthracene, trans-8,9-dihydroxy-8,9-dihydrobenzo[a]anthracene, 7,12-dimethylbenz[a]anthracene and its cis-5,6-dihydrodiol, 5-methylchrysene, 11,12-dihydroxy-11,12-dihydro-3-methylcholanthrene, 1,2-dihydroxy-1,2-dihydro-6-methylchrysene, benzo[c]phenanthrene, 2-amino-6-methyldipyridol[1,2-a:3',2'-d]imidazole, 2-acetylaminofluorene, benzidine, 2-naphthylamine, aflatoxin B1, aflatoxin G1, sterigmatocystin, N-nitrosodimethylamine, vinyl carbamate, or acrylonitrile in this assay system. P450 1B1 is expressed constitutively in extrahepatic organs, including fetal tissue samples, and is highly inducible in various organs by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds in experimental animal models. Thus, activation of procarcinogens by P450 lB1 may contribute to human tumors of extrahepatic origin.
Citing Articles
Exploring anticancer potential of betanin in DMBA-induced oral squamous cell carcinoma: an in silico and experimental study.
Duraisamy R, Veerasamy V, Balakrishnan V, Jawaharlal S, Subramani S, Sathiavakoo V
Naunyn Schmiedebergs Arch Pharmacol. 2025; .
PMID: 40009172
DOI: 10.1007/s00210-025-03909-2.
Human Cytochrome P450 Cancer-Related Metabolic Activities and Gene Polymorphisms: A Review.
Mokhosoev I, Astakhov D, Terentiev A, Moldogazieva N
Cells. 2024; 13(23).
PMID: 39682707
PMC: 11639897.
DOI: 10.3390/cells13231958.
High Expression of AhR and Environmental Pollution as AhR-Linked Ligands Impact on Oncogenic Signaling Pathways in Western Patients with Gastric Cancer-A Pilot Study.
Perrot-Applanat M, Pimpie C, Vacher S, Pocard M, Baud V
Biomedicines. 2024; 12(8).
PMID: 39200369
PMC: 11351739.
DOI: 10.3390/biomedicines12081905.
Gut microbiota carcinogen metabolism causes distal tissue tumours.
Roje B, Zhang B, Mastrorilli E, Kovacic A, Susak L, Ljubenkov I
Nature. 2024; 632(8027):1137-1144.
PMID: 39085612
PMC: 11358042.
DOI: 10.1038/s41586-024-07754-w.
Gender Difference in DNA Damage Induced by the Environmental Carcinogen Dibenzo[]chrysene Individually and in Combination with Mouse Papillomavirus Infection in the Mouse Oral Cavity.
Chen K, Sun Y, Hu J, Balogh K, Gowda K, Aliaga C
ACS Omega. 2024; 9(7):8434-8438.
PMID: 38405470
PMC: 10882652.
DOI: 10.1021/acsomega.3c09611.
Lower overall survival in male patients with advanced disease undergoing allogeneic hematopoietic stem cell transplantation is associated with Leu432Val polymorphism.
Stute N, Koldehoff M
Haematologica. 2023; 109(3):799-808.
PMID: 37767566
PMC: 10905095.
DOI: 10.3324/haematol.2023.283649.
Evaluation of the ability of fatty acid metabolism signature to predict response to neoadjuvant chemoradiotherapy and prognosis of patients with locally advanced rectal cancer.
Zhou H, Chen Y, Xiao Y, Wu Q, Li H, Li Y
Front Immunol. 2022; 13:1050721.
PMID: 36505493
PMC: 9729334.
DOI: 10.3389/fimmu.2022.1050721.
3D-QSAR assisted identification of selective CYP1B1 inhibitors: an effective bioisosteric replacement/molecular docking/electrostatic complementarity analysis.
Raju B, Sapra B, Silakari O
Mol Divers. 2022; 27(6):2673-2693.
PMID: 36441444
DOI: 10.1007/s11030-022-10574-7.
CYP1B1 Augments the Mesenchymal, Claudin-Low, and Chemoresistant Phenotypes of Triple-Negative Breast Cancer Cells.
Hollis P, Mobley R, Bhuju J, Abell A, Sutter C, Sutter T
Int J Mol Sci. 2022; 23(17).
PMID: 36077068
PMC: 9456208.
DOI: 10.3390/ijms23179670.
Ancestral Sequence Reconstruction of a Cytochrome P450 Family Involved in Chemical Defense Reveals the Functional Evolution of a Promiscuous, Xenobiotic-Metabolizing Enzyme in Vertebrates.
Harris K, Thomson R, Gumulya Y, Foley G, Carrera-Pacheco S, Syed P
Mol Biol Evol. 2022; 39(6).
PMID: 35639613
PMC: 9185370.
DOI: 10.1093/molbev/msac116.
In Silico Design and SAR Study of Dibenzyl Trisulfide Analogues for Improved CYP1A1 Inhibition.
Clarke N, Irvine W
ChemistryOpen. 2022; 11(5):e202200016.
PMID: 35610057
PMC: 9130049.
DOI: 10.1002/open.202200016.
CYP1B1 converts procarcinogens into genotoxins in Saccharomyces cerevisiae.
Kannan A, Perpetua N, Dolan M, Fasullo M
Mutat Res Genet Toxicol Environ Mutagen. 2022; 874-875:503440.
PMID: 35151423
PMC: 10276974.
DOI: 10.1016/j.mrgentox.2022.503440.
Prioritization of Mycotoxins Based on Their Genotoxic Potential with an In Silico-In Vitro Strategy.
Alonso-Jauregui M, Font M, Gonzalez-Penas E, Lopez de Cerain A, Vettorazzi A
Toxins (Basel). 2021; 13(10).
PMID: 34679027
PMC: 8540412.
DOI: 10.3390/toxins13100734.
Oleuropein-Induced Acceleration of Cytochrome P450-Catalyzed Drug Metabolism: Central Role for Nuclear Receptor Peroxisome Proliferator-Activated Receptor α.
Malliou F, Andriopoulou C, Gonzalez F, Kofinas A, Skaltsounis A, Konstandi M
Drug Metab Dispos. 2021; 49(9):833-843.
PMID: 34162688
PMC: 11022892.
DOI: 10.1124/dmd.120.000302.
Cigarette smoke exposure and alveolar macrophages: mechanisms for lung disease.
Lugg S, Scott A, Parekh D, Naidu B, Thickett D
Thorax. 2021; 77(1):94-101.
PMID: 33986144
PMC: 8685655.
DOI: 10.1136/thoraxjnl-2020-216296.
Role of Genetic Variation in Cytochromes P450 in Breast Cancer Prognosis and Therapy Response.
Hlavac V, Vaclavikova R, Brynychova V, Ostasov P, Kozevnikovova R, Kopeckova K
Int J Mol Sci. 2021; 22(6).
PMID: 33802237
PMC: 8001203.
DOI: 10.3390/ijms22062826.
Dibenzyl trisulfide binds to and competitively inhibits the cytochrome P450 1A1 active site without impacting the expression of the aryl hydrocarbon receptor.
Wauchope S, Roy M, Irvine W, Morrison I, Brantley E, Gossell-Williams M
Toxicol Appl Pharmacol. 2021; 419:115502.
PMID: 33774063
PMC: 8372549.
DOI: 10.1016/j.taap.2021.115502.
Drug-Metabolizing Cytochrome P450 Enzymes Have Multifarious Influences on Treatment Outcomes.
Song Y, Li C, Liu G, Liu R, Chen Y, Li W
Clin Pharmacokinet. 2021; 60(5):585-601.
PMID: 33723723
DOI: 10.1007/s40262-021-01001-5.
Kynurenine-Induced Aryl Hydrocarbon Receptor Signaling in Mice Causes Body Mass Gain, Liver Steatosis, and Hyperglycemia.
Rojas I, Moyer B, Ringelberg C, Wilkins O, Pooler D, Ness D
Obesity (Silver Spring). 2021; 29(2):337-349.
PMID: 33491319
PMC: 10782555.
DOI: 10.1002/oby.23065.
Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.
Rendic S, Guengerich F
Arch Toxicol. 2021; 95(2):395-472.
PMID: 33459808
PMC: 7880545.
DOI: 10.1007/s00204-020-02971-4.